Clovis Oncology Inc.

12/29/2020 | Press release | Distributed by Public on 12/29/2020 07:06

Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial